New CMS rule promotes payer drug price negotiations based on clinical outcomes

(By Maia Anderson for Becker’s Hospital Review)

CMS issued a proposed rule June 17 that would make it easier for Medicaid to make payment models based on a drug’s clinical value.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org